Real-world treatment chronic migraine in Poland.
作者信息
Domitrz Izabela, Karaszewski Bartosz, Stępień Adam
机构信息
Department of Neurology, Faculty of Medicine and Dentistry, Medical University of Warsaw, Bielanski Hospital, Warsaw, Poland.
Department of Adult Neurology, Medical University of Gdansk, University Clinical Centre, Gdansk, Poland.
出版信息
Arch Med Sci. 2024 Dec 31;20(6):2082-2084. doi: 10.5114/aoms/197281. eCollection 2024.
Abstract
摘要
相似文献
1
Real-world treatment chronic migraine in Poland.波兰慢性偏头痛的真实世界治疗情况。
Arch Med Sci. 2024 Dec 31;20(6):2082-2084. doi: 10.5114/aoms/197281. eCollection 2024.
2
Treatment and management of migraine in neurological ambulatory practice in Poland by indicating therapy with monoclonal anti-CGRP antibodies.在波兰的神经科门诊实践中，通过使用单克隆抗 CGRP 抗体进行治疗，对偏头痛进行治疗和管理。
Neurol Neurochir Pol. 2020;54(4):337-343. doi: 10.5603/PJNNS.a2020.0054. Epub 2020 Jul 20.
3
Experience of treatment of chronic migraine with botulinum toxin type A among aesthetic medicine professionals in Poland.波兰美容医学专业人员治疗慢性偏头痛的肉毒毒素 A 治疗经验。
Neurol Neurochir Pol. 2023;57(4):363-370. doi: 10.5603/PJNNS.a2023.0049. Epub 2023 Jul 24.
4
Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study.真实世界中静脉注射依替替硝唑治疗慢性偏头痛患者的疗效和满意度：一项基于美国多中心观察性研究。
J Headache Pain. 2024 Apr 25;25(1):65. doi: 10.1186/s10194-024-01764-9.
5
Migraine diagnosis and treatment in Poland: survey of primary care practitioners.波兰的偏头痛诊断和治疗：初级保健医生调查。
Neurol Neurochir Pol. 2021;55(4):380-386. doi: 10.5603/PJNNS.a2021.0045. Epub 2021 Jun 16.
6
Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort : Results from 'Migraine in Poland'-a nationwide cross-sectional survey.偏头痛症状、医疗资源利用和波兰大规模偏头痛队列的疾病负担：来自“波兰偏头痛”全国性横断面调查的结果。
J Headache Pain. 2023 Apr 11;24(1):40. doi: 10.1186/s10194-023-01575-4.
7
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE.阿联酋慢性或阵发性偏头痛患者依瑞奈玛单抗的真实世界经验。
BMC Neurol. 2022 Jun 16;22(1):221. doi: 10.1186/s12883-022-02710-5.
8
Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data.肉毒毒素 A（保妥适®）预防治疗慢性偏头痛的有效性：基于 10 年真实世界数据的荟萃分析。
Cephalalgia. 2022 Dec;42(14):1543-1564. doi: 10.1177/03331024221123058. Epub 2022 Sep 8.
9
Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study.依瑞奈尤单抗用于慢性和阵发性偏头痛预防性治疗的真实世界持久性：回顾性真实世界研究。
Headache. 2022 Jan;62(1):78-88. doi: 10.1111/head.14218. Epub 2021 Nov 22.
10
Generalizability of clinical trial efficacy results to a real-world population: An example in migraine prevention.临床试验疗效结果在真实人群中的可推广性：偏头痛预防的一个实例。
J Manag Care Spec Pharm. 2023 Dec;29(12):1321-1330. doi: 10.18553/jmcp.2023.29.12.1321.
本文引用的文献
1
The Polish Experts' Consensus Statement: 2023 update on new therapies for migraine.《波兰专家共识声明：2023年偏头痛新疗法更新》
Arch Med Sci. 2024 Jan 12;20(1):339-343. doi: 10.5114/aoms/175063. eCollection 2024.
2
The Polish Headache Society and the Headache Section of the Polish Neurological Society Consensus Statement: update on new pharmacological therapies for migraine in clinical practice and public medication reimbursement program for chronic migraine.波兰头痛协会和波兰神经学会头痛分会共识声明：偏头痛临床实践中新药物疗法及慢性偏头痛公共药物报销计划的更新
Arch Med Sci. 2022 Nov 7;18(6):1705-1707. doi: 10.5114/aoms/153955. eCollection 2022.
3
The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates.全球头痛患病率：更新报告，并分析方法学因素对患病率估计的影响。
J Headache Pain. 2022 Apr 12;23(1):34. doi: 10.1186/s10194-022-01402-2.
4
Migraine: epidemiology and systems of care.偏头痛：流行病学和照护体系。
Lancet. 2021 Apr 17;397(10283):1485-1495. doi: 10.1016/S0140-6736(20)32160-7. Epub 2021 Mar 25.
5
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担：2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
6
Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.偏头痛生活：慢性偏头痛流行病学和结果（CaMEO）研究对人际关系、职业和财务的影响。
Headache. 2019 Sep;59(8):1286-1299. doi: 10.1111/head.13613. Epub 2019 Aug 12.
7
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.国际头痛协会（IHS）头痛分类委员会《国际头痛疾病分类》第三版
Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202.
8
Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants.偏头痛影响着全球十分之一的人口，且发病率呈上升趋势：一项对涉及600万参与者的社区研究的系统评价和荟萃分析。
J Neurol Sci. 2017 Jan 15;372:307-315. doi: 10.1016/j.jns.2016.11.071. Epub 2016 Dec 3.
Zotero 插件